| GDDIS 2011 Confirmed Speakers |
|
Dr. Michael E. Burczynski
Global Head of Pharmacogenomics & Site Head for Translational Research Sciences, Roche
|
| Dr. Michael E. Burczynski is currently the Global Head of Genomics and Genetics in Translational Research Sciences within Roche’s Pharmaceutical Research and Early Development (pRED). He previously led the Clinical... |
full profile »
|
 |
Rod Mackenzie
Senior Vice President
Head of PharmaTherapeutics Research and Development Pfizer, Inc
|
| Rod MacKenzie is Senior Vice President, Head of Worldwide Research for the PharmaTherapeutics division of Pfizer. He leads the organisation responsible for bringing forward the next generation of positive Proof of Concept molecules to... |
| |
full profile »
|
 |
Ted Torphy, Ph.D.
Vice President & Head, External Innovation
Research Capabilities Johnson & Johnson Pharmaceuticals
|
Ted Torphy is now Vice President & Lead, External Innovation
Research Capabilities but was recently Chief Scientific Officer and Head of External Research & Early Development (eRED) for Johnson & Johnson’s Pharmaceuticals Group... |
| |
full profile »
|
|
Jean-Pierre Bizzari,
M.D.Senior Vice President Clinical Research-Oncology
Celgene
|
| Dr Bizzari holds a medical degree from the University of Nice (France) and trained as an oncologist at the Pitie Salpetriere hospital in Paris. He trained successively in Toronto (Ontario Cancer Institute - Canada) and Montreal... |
full profile »
|
|
Claudine Grépin,
Assay Sciences and Screening,
Sanofi-Aventis, France
|
| 2010-pres: Lead Generation Business Coordinator for Oncology and Head of Kinase and High Content Screening Expertise Center, Vitry . Lead Identification Technology, Sanofi-Aventis, France... |
full profile »
|
|
Dr Anthony Mitchell Davies
Director High Content Research Facility,
Trinity College Dublin
|
| Dr Anthony Mitchell Davies has worked in cell based assay development for over a decade and now holds position the Director of the High Content Facility at Trinity College Dublin. Dr Davies has been responsible for the set up... |
full profile »
|
|
Jozsef Repasi
Managing Director
Ubichem Research Ltd
|
| Jozsef Repasi is Managing Director at Ubichem Research Ltd. and director of Ubichem Plc. He has held his managing director position since the creation of the company in 1996. Répási earned a Masters Degree in Science, specializing in |
full profile »
|
|
Prof. Dr. med. Khusru Asadullah
Vice President, Head of Target Discovery
Bayer HealthCare Pharmaceuticals
|
| Khusru Asadullah is Vice President and Head of Target Discovery at Bayer HealthCare Pharmaceuticals.. Before this he headed Inflammation and Immunology research at Bayer Schering Pharma... |
full profile »
|
|
Tom D. Heightman
Director of Medicinal Chemistry
Astex Therapeutics
|
| Tom Heightman is a Director of Medicinal Chemistry at Astex in Cambridge, UK. Tom studied Chemistry at Oxford, and gained his PhD at the ETH in Zurich. In 1998 he joined GlaxoSmithKline in Harlow, UK... |
full profile »
|
|
James E. Bradner, M.D. M.Sc.
Instructor, Department of Medicine, Harvard Medical School
Instructor in Medicine, Hematologic Neoplasia/Malignancies, Dana-Farber Cancer Institute
|
| James E. Bradner, MD is a Staff Physician in the Division of Hematologic Malignancies at Dana-Farber Cancer Institute as well as an Assistant Professor in Medicine at Harvard Medical School. |
full profile »
|
|
John Burke
Associate Director of Systems Biology at Boehringer Ingelheim
|
| Awarded Ph.D. in Mathematics, with Frank C. Hoppensteadt, Arizona State University, studying dynamic canonical mathematical models of gene regulation and cellular signaling cascades, 2003. Postdoctoral work with Douglas A... |
full profile »
|
| |
|
|
|
|
Eric D Perakslis PhD
Vice President of R&D Information Technology
Johnson & Johnson Pharmaceuticals R&D
|
| Eric is currently Vice President of R&D Information Technology at Johnson & Johnson Pharmaceuticals R&D and is a member of the Corporate Office of Science and Technology. Eric is in his thirteenth year at J&J and has held the posts of... |
full profile »
|
 |
John Burkhardt
Global Head of Preclinical Safety
Abbott Laboratories
|
| John Burkhardt is Global Head of Preclinical Safety at Abbott Laboratories, where he is responsible for all aspects of Toxicology, Pathology, Comparative Medicine, and related fields... |
| |
full profile »
|
|
Hans-Joachim Böhm
Global Head of Chemistry
Roche
|
| Hans-Joachim Böhm is Global Head of Chemistry at Roche and Center Manager for the Roche Pharma Research and Early Development Site Basel. Prior to this, Hans-Joachim Böhm was President and Research Site Head of Roche... |
full profile »
|
 |
Dr Duncan McHale
Vice President, Translational Science,
AstraZeneca
|
| After completing his medical degree at Newcastle University in 1991 Duncan trained in General Medicine gaining his Membership of the Royal College of Physicians in 1994. He spent 5 years training in clinical and molecular genetics at... |
| |
full profile »
|
 |
Dr. Thomas Bocan
Senior Director & Head of Pfizer’s PharmaTherapeutics Preclinical BioImaging facility
|
| Dr. Bocan received his PhD in Physiology with an emphasis in Experimental Pathology from The Pennsylvania State University in 1983 and did post-doctoral research in atherosclerosis at the Baylor College of Medicine... |
| |
full profile »
|
 |
Steven Hutchins, Senior Vice President
Strategic Business Development,
Evotec
|
| Mr. Hutchins has 20 years of pharmaceutical industry experience. He worked at Merck from 1990 to 2007 initially as a medicinal and combinatorial chemist. He began his career in outsourcing of chemistry services at Merck in 1995. |
full profile »
|
|
Joseph Donahue VP
SVP, Global Sales
Thomson Reuters
|
| Joe Donahue is Vice President, Commercial Operations Life Sciences at Thomson Reuters Healthcare & Science. Mr. Donahue has more than fifteen years of executive level entrepreneurial and Board experience in global life sciences... |
full profile »
|
 |
Stevan W Djuric, PhD
Senior Director, Global Pharmaceutical Research and Development, Medicinal Chemistry Technologies and Structural Chemistry, Abbott
|
| Dr Stevan Djuric is responsible for the Medicinal Chemistry Technology and Structural Chemistry groups at Abbott Laboratories. Their current efforts are focused on new initiatives in the areas of high throughput synthesis and... |
| |
full profile »
|
 |
Dr. Joyce Peng
Marketing Director
BGI Americas
|
| Dr. Joyce Peng has established herself as a prominent voice for the application of state-of-the art technologies in the life sciences field. Joyce has been promoting bioinformatics and elated products at various organizations and is now... |
| |
full profile »
|
 |
Sid Bhoopathy, Ph.D
Chief Operating Officer
Absorption Systems
|
| Dr. Bhoopathy is Chief Operating Officer at Absorption Systems. Prior to being named COO, Dr. Bhoopathy was Vice President of Operations and has held various positions within the company since 2004... |
| |
full profile »
|
 |
Daniel L. Weiner, Ph.D.
General Manager, Software Products and Sr. Vice President, Certara™ Corporation
|
| Dr. Weiner has extensive drug development experience and has served as an expert consultant to the U.S. Food and Drug Administration (FDA) on pharmacokinetic modeling and bioequivalence assessment. Prior to his previous tenure... |
| |
full profile »
|
|
Steve Shamah, Ph.D.
Director of Cell Biology
SRU Biosystems, Inc.
|
| Steven R. Shamah, Ph.D. has been the Director of Cell Biology and Member of the Management Team at SRU Biosystems, Inc. since May 2009 and is responsible for the development of cell-based, label-free applications for... |
full profile »
|
| |
|
|
